Amanote Research
Register
Sign In
KRAS-Driven Cancers Are Dependent on METTL13-Mediated eEF1A Methylation
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2019-005
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
January 11, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis
Cell
Biochemistry
Genetics
Molecular Biology
MYC-Driven Tumors Are Dependent on CDK9-Mediated Transcription Elongation
Cancer Discovery
Oncology
Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers
Nature
Multidisciplinary
Tissue of Origin Dictates Branched-Chain Amino Acid Metabolism in Mutant Kras-Driven Cancers
Science
Multidisciplinary
Philosophy of Science
History
Mitochondrial Metabolism and ROS Generation Are Essential for Kras-Mediated Tumorigenicity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Regulation of Eukaryotic Elongation Factor 1 Alpha (eEF1A) by Dynamic Lysine Methylation
RNA Biology
Cell Biology
Molecular Biology
Effects of PTCs on Nonsense‑mediated mRNA Decay Are Dependent on PTC Location
Oncology Letters
Cancer Research
Oncology
DNA Methylation in Breast and Colorectal Cancers
Modern Pathology
Forensic Medicine
Pathology
Are All Incidental Gallbladder Cancers Truly Incidental? Or, Are Some Missed Cancers?
HPB
Hepatology
Gastroenterology